Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Current Assets (2016 - 2025)

Pediatrix Medical (MD) has disclosed Current Assets for 17 consecutive years, with $763.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Current Assets rose 19.37% to $763.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $763.5 million, a 19.37% increase, with the full-year FY2025 number at $763.5 million, up 19.37% from a year prior.
  • Current Assets was $763.5 million for Q4 2025 at Pediatrix Medical, up from $717.2 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $840.6 million in Q4 2021 to a low of $397.8 million in Q2 2023.
  • A 5-year average of $555.8 million and a median of $487.6 million in 2023 define the central range for Current Assets.
  • Peak YoY movement for Current Assets: crashed 52.27% in 2021, then skyrocketed 42.83% in 2025.
  • Pediatrix Medical's Current Assets stood at $840.6 million in 2021, then crashed by 49.08% to $428.0 million in 2022, then increased by 12.96% to $483.5 million in 2023, then skyrocketed by 32.3% to $639.6 million in 2024, then increased by 19.37% to $763.5 million in 2025.
  • Per Business Quant, the three most recent readings for MD's Current Assets are $763.5 million (Q4 2025), $717.2 million (Q3 2025), and $613.0 million (Q2 2025).